drugset / Trial / NCT04039373

Effects of BMS-986256 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate Mofetil

NCT04039373

Phase 1 Completed 15 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelPrevention

Summary

A Study to Investigate BMS-986256 at steady state and its effect on Mycophenolate Mofetil exposure in Healthy Male Participants

Timeline

Start
2019-07-22
Primary completion
2019-09-18
Completion
2019-10-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Afimetoran Small molecule
Subject Mycophenolate Mofetil Small molecule

Indications

No indication recorded.